Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial
Article in Diabetes Obesity and Metabolism (March 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Diabetes Obesity and Metabolism (March 2024)
Article in CardioVasc (February 2024)
Article in Cardiology in Review (February 2024)